Genetic Studies of Leptin Concentrations Implicate Leptin in the Regulation of Early Adiposity

dc.contributor.authorYaghootkar, Hanieh
dc.contributor.authorZhang, Yiying
dc.contributor.authorSpracklen, Cassandra N.
dc.contributor.authorKaraderi, Tugce
dc.contributor.authorHuang, Lam Opal
dc.contributor.authorBradfield, Jonathan
dc.contributor.authorKilpelainen, Tuomas O.
dc.date.accessioned2026-02-06T18:27:00Z
dc.date.issued2020
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractLeptin influences food intake by informing the brain about the status of body fat stores. Rare LEP mutations associated with congenital leptin deficiency cause severe early-onset obesity that can be mitigated by administering leptin. However, the role of genetic regulation of leptin in polygenic obesity remains poorly understood. We performed an exome-based analysis in up to 57,232 individuals of diverse ancestries to identify genetic variants that influence adiposity-adjusted leptin concentrations. We identify five novel variants, including four missense variants, in LEP, ZNF800, KLHL31, and ACTL9, and one intergenic variant near KLF14. The missense variant Val94Met (rs17151919) in LEP was common in individuals of African ancestry only, and its association with lower leptin concentrations was specific to this ancestry (P = 2 x 10(-16), n = 3,901). Using in vitro analyses, we show that the Met94 allele decreases leptin secretion. We also show that the Met94 allele is associated with higher BMI in young African-ancestry children but not in adults, suggesting that leptin regulates early adiposity.
dc.description.sponsorshipData Tecnica International; National Institute on Aging, National Institutes of Health; Johnson Johnson; NHGRI NIH [F31HG009850]; National Heart Lung and Blood Institute [R01HL149683, R01HL105756] Funding Source: NIH RePORTER; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK020541] Funding Source: NIH RePORTER; MRC [MC_UU_00006/1, MC_UU_12015/1, MR/T002239/1] Funding Source: UKRI; Danish Diabetes and Endocrine Academy [PhD006-18, PD001-18] Funding Source: researchfish; Medical Research Council [MC_UU_12015/1, MR/T002239/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0617-10149] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Grarup Group, Kilpeläinen Group, Hansen Group] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Søren Brunak] Funding Source: researchfish
dc.description.sponsorshipThe funding information for all participating studies are provided in the Supplementary Material. D.M.-K. is a part-time clinical research consultant for Metabolon, Inc. M.A.N.'s participation is supported by a consulting contract between Data Tecnica International and the National Institute on Aging, National Institutes of Health. V.S. has served on advisory boards for Novo Nordisk and Sanofi and received honoraria from these companies. V.S. also has ongoing research collaboration with Bayer Ltd. B.M.P. serves on the Steering Committee of the Yale Open Data Access Project funded by Johnson & Johnson. J.R. K. reports stock ownership in Bristol-Myers Squibb, Johnson & Johnson, Merck, and Pfizer. R. S.F. is currently an employee of Vertex Pharmaceuticals Incorporated, though all work for this article was done prior to Vertex affiliation. This work was supported by NHGRI NIH F31HG009850. E. I. is now an employee of GlaxoSmithKline, but this work was done prior to joining the company. No other potential conflicts of interest relevant to this article were reported.
dc.identifier.doi10.2337/db20-0070
dc.identifier.endpage2818
dc.identifier.issn0012-1797
dc.identifier.issn1939-327X
dc.identifier.issue12
dc.identifier.orcid0000-0001-8285-7523
dc.identifier.orcid0000-0002-2167-7470
dc.identifier.orcid0000-0001-7592-0942
dc.identifier.orcid0000-0001-7914-4709
dc.identifier.orcid0000-0003-4282-1344
dc.identifier.orcid0000-0003-0011-123X
dc.identifier.orcid0000-0001-7999-5538
dc.identifier.pmid32917775
dc.identifier.scopus2-s2.0-85096618864
dc.identifier.scopusqualityQ1
dc.identifier.startpage2806
dc.identifier.urihttps://doi.org/10.2337/db20-0070
dc.identifier.urihttps://hdl.handle.net/11129/10751
dc.identifier.volume69
dc.identifier.wosWOS:000594819600025
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherAmer Diabetes Assoc
dc.relation.ispartofDiabetes
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260204
dc.subjectGenome-Wide Association
dc.subjectPlasma Leptin
dc.subjectObesity
dc.subjectLoci
dc.subjectRare
dc.subjectVariants
dc.subjectMetaanalysis
dc.subjectExpenditure
dc.subjectHomeostasis
dc.subjectDeficiency
dc.titleGenetic Studies of Leptin Concentrations Implicate Leptin in the Regulation of Early Adiposity
dc.typeArticle

Files